Premier (PINC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
9 Jan, 2026Executive summary
Revenue and profitability for the first half of fiscal 2025 met expectations, with Supply Chain Services outperforming and Performance Services underperforming; Q2 net revenue was $240.3M, down 14% year-over-year.
The company reaffirmed total net revenue and adjusted EBITDA guidance midpoints, and raised the midpoint for adjusted EPS guidance by $0.08, reflecting confidence in ongoing execution.
Significant portfolio adjustments included the completed divestitures of S2S Global (October 2024) and Contigo Health network assets (January 2025), with further asset sales in progress.
Results reflect a $126.8M goodwill impairment in Performance Services and a $51.7M loss on the S2S Global divestiture.
Leadership changes and talent recruitment are underway to reinvigorate Performance Services.
Financial highlights
Q2 net revenue was $240.3M, down 14% year-over-year, driven by declines in both Supply Chain Services and Performance Services.
GAAP net loss from continuing operations was $45.8M, mainly due to a $126.8M goodwill impairment in Performance Services.
Adjusted EBITDA was $50.1M (20.8% margin), down 48% year-over-year; adjusted EPS was $0.25 ($0.27 excluding Contigo Health), down 51% year-over-year.
Free cash flow for the first half was $73.9M, up $33M year-over-year, aided by a derivative lawsuit settlement and a minority investment distribution.
Cash and cash equivalents at quarter-end were $85.9M; $100M outstanding on the $1B credit facility, with $65M repaid in January 2025.
Outlook and guidance
Fiscal 2025 total net revenue guidance (excluding Contigo Health): $940M–$1.01B, with the midpoint reaffirmed.
Adjusted EBITDA guidance: $237M–$253M; adjusted EPS guidance raised to $1.26–$1.34.
Net administrative fees revenue guidance increased to $525M–$545M; capital expenditures expected at $90M–$100M; effective tax rate 24%–26%.
Profitability (adjusted EBITDA and EPS) expected to be more weighted to Q4 due to timing and mix of revenue.
Management expects continued pressure on net administrative fees due to higher fee shares in renewed GPO contracts and ongoing market and regulatory uncertainties.
Latest events from Premier
- Q4 revenue up 3%, FY25 guidance targets $1.02B revenue, $1.28 EPS, excluding divestitures.PINC
Q4 202423 Jan 2026 - Q1 net income rose to $72.9M on $248.1M revenue, driven by a $57M legal settlement.PINC
Q1 202516 Jan 2026 - Technology-driven growth, new leadership, and capital returns support long-term value.PINC
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - AI-driven supply chain and shared services are key to transformative savings and future growth.PINC
Leerink’s Global Healthcare Conference 202518 Dec 2025 - Definitive merger agreement for $28.25/share cash buyout, board-approved, pending shareholder vote.PINC
Proxy Filing1 Dec 2025 - Shareholders to vote on $28.25 per share all-cash merger, board unanimously recommends approval.PINC
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong ESG focus.PINC
Proxy Filing1 Dec 2025 - Shareholders to vote on a $28.25 per share all-cash merger, unanimously backed by the board.PINC
Proxy Filing1 Dec 2025 - Acquisition by Patient Square Capital will take the company private, pending approvals.PINC
Proxy Filing1 Dec 2025